Novartis freezes drug prices for 2018 — 3 insights

Novartis will not raise prices for any of its U.S.-based prescription offerings in 2018, CNN reports.

Here's what you should know:

1. Novartis CEO Vas Narasimhan said the company won't raise the prices of its prescription drugs in 2018, but it will evaluate the healthcare legislative environment as it evolves.

2. Novartis originally planned increases for the third quarter of 2018.

3. The company said in a statement, "We work with governments and healthcare stakeholders in all the countries we serve, to support policies to ensure the development of and access to medicines that can improve and extend our patients' lives."

More articles on supply chain:
Key Surgical, ModMed & more — 3 GI company key notes
10 things to know about ASC coding audits
GI residents earn over $64K — Here's which specialties rake in more

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months